Peru

Last Updated 20 October 2021.

4 Vaccines Approved for Use in Peru

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 103 countries

  37 trials in 2 countries

  Approval Source: reuters.com

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 75 countries

  13 trials in 16 countries

  Approval Source: gob.pe

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 124 countries

  45 trials in 23 countries

  Approval Source: digemid.minsa.gob.pe

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  BBIBP-CorV (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 67 countries

  14 trials in 2 countries

  Approval Source: reuters.com

  Inactivated

3 Vaccines in Clinical Trials in Peru

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 75 countries

  13 trials in 16 countries

  Non Replicating Viral Vector

• Sinopharm (Wuhan)
  Inactivated (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  8 trials in 7 countries

  Inactivated

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 124 countries

  45 trials in 23 countries

  Non Replicating Viral Vector